Figure 7.
Treatment of TMV.MP-GFP Infection Sites with Proteasome Inhibitors.
(A) TMV.MPWT-GFP infection site showing MT labeling at the trailing edge of infection. Bar = 20 μm.
(B) TMV.MPWT-GFP infection site after treatment with clasto-lactacystin β-lactone. Note the punctate appearance of MPWT-GFP in infected cells. Bar = 20 μm.
(C) TMV.MPWT-DsRed infection site on an erGFP transgenic plant after treatment with clasto-lactacystin β-lactone. MPWT-DsRed is localized to the vertices of the cortical ER network. Bar = 15 μm.
(D) and (E) TMV.MPR3-GFP infection site before (D) and after (E) treatment with clasto-lactacystin β-lactone. Bar = 20 μm.